Sign in

CIK 0001503802

  • Non-accelerated filer
  • Smaller reporting company

Karyopharm Therapeutics Inc.

Sign in to watch
Tickers
KPTI KPTIQ
Exchange
Nasdaq, OTC
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
263931704
Phone
+1 617-658-0600
Business address
85 WELLS AVENUE, SECOND FLOOR, NEWTON, MA, 02459

Securities

  • KPTI Common stock Nasdaq
  • KPTIQ Common stock OTC
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$2,135
in 3 filings

Net −$2,135. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Pace of trading Bought Sold

Who's trading

90 days

  1. Abate Kristin −$2K Chief Accounting Officer sold 22% of stake

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2021-02-25 Frenkel Ran EVP, Chief Dev. Officer Grant or award +22,013 104,439
2021-02-25 Frenkel Ran EVP, Chief Dev. Officer Grant or award · Stock Option (right to buy) +59,968 59,968
2021-02-25 DEMAREE JOHN Chief Commercial Officer Grant or award +15,849 23,995
2021-02-25 DEMAREE JOHN Chief Commercial Officer Grant or award · Stock Option (right to buy) +43,177 43,177
2021-02-25 Shacham Sharon President & CSO Grant or award +57,200 920,152
2021-02-25 Shacham Sharon President & CSO Grant or award +57,200 718,826
2021-02-25 Shacham Sharon President & CSO Grant or award · Stock Option (right to buy) +153,500 153,500
2021-02-25 Shacham Sharon President & CSO Grant or award · Stock Option (right to buy) +153,500 153,500
2021-02-25 Kauffman Michael Chief Executive Officer Grant or award +57,200 718,826
2021-02-25 Kauffman Michael Chief Executive Officer Grant or award +57,200 920,152
2021-02-25 Kauffman Michael Chief Executive Officer Grant or award · Stock Option (right to buy) +153,500 153,500
2021-02-25 Kauffman Michael Chief Executive Officer Grant or award · Stock Option (right to buy) +153,500 153,500
2021-02-18 Shah Jatin EVP, Chief Medical Officer Sale −1,186 $14.83 $18K 51,791
2021-02-18 Frenkel Ran EVP, Chief Dev. Officer Sale −2,887 $14.83 $43K 46,126
2021-02-18 Shacham Sharon President & CSO Sale −9,495 $14.83 $141K 776,452
2021-02-18 Shacham Sharon President & CSO Sale −9,495 $14.83 $141K 575,126
2021-02-18 Kauffman Michael Chief Executive Officer Sale −9,495 $14.83 $141K 575,126
2021-02-18 Kauffman Michael Chief Executive Officer Sale −9,495 $14.83 $141K 776,452
2021-02-15 Shah Jatin EVP, Chief Medical Officer Exercise or conversion +4,850 52,977
2021-02-15 Shah Jatin EVP, Chief Medical Officer Exercise or conversion · Restricted Stock Units −4,850 9,700

Page 17 of 29 · 570 trades